EPM
CPXX

Equitec Proprietary Markets’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Equitec Proprietary Markets’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,467
Closed -$256K – 175
2016
Q2 		$256K Buy
+8,467
New +$172K 0.01% 87

Equitec Proprietary Markets's CPXX Position: Q3 2016 in Review

Equitec Proprietary Markets sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 8,467 shares — an estimated $256K sold.

Equitec Proprietary Markets first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $256K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Equitec Proprietary Markets reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Equitec Proprietary Markets sold 8,467 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $256K.
  • Equitec Proprietary Markets first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Equitec Proprietary Markets's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $256K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Equitec Proprietary Markets's 13F filing for Q3 2016, filed 24 Oct 2016.